Effects of health insurance on racial disparity in osteoporosis medication adherence

Ji Won Yoo, Sulgi Kim, Sun Jung Kim, Woo Sang Ryu, Too Jae Min, Hyun Phil Shin, Kyudam Kim, Jong Bum Choi, Shunichi Nakagawa

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective: To explore whether racial disparity in osteoporosis drug therapy maintenance varies by health insurance coverage status. Design: Longitudinal observation study. Setting: Cleveland Clinic Health System (Cleveland, OH) from January 2006 to December 2009. Patients: 3,901 black and white female Medicare beneficiaries starting osteoporosis drug therapy. Intervention: Analysis of the health system's integrated electronic medical records. Main outcome measures: Drug therapy adherence (medication possession ratio ≥80%) for more than 12 of 15 surveillance units and occurrence of extended nonadherence gaps for at least two surveillance units in a row. Results: Among patients with supplementary health insurance (n = 2,278), no difference was observed for drug therapy adherence (P = 0.17) and extended nonadherence gaps (P = 0.53) between black and white participants. When patients did not have supplementary health insurance (n = 1,623), blacks (36% [95% CI 28-47]) were less likely to adhere to drug therapy than whites (47% [38-57]; odds ratio [OR] 0.34 [95% CI 0.09-0.92], P = 0.004). Blacks (25% [19-32]) also were more likely to have an extended nonadherence gap episode than whites (18% [11-26]; OR 2.42 [1.13-3.50], P = 0.03). Conclusion: Similar to previous research on racial disparity in health services, racial disparity in osteoporosis drug therapy maintenance between black and white female older patients existed when supplementary health insurance was not affordable.

Original languageEnglish
Pages (from-to)626-631
Number of pages6
JournalJournal of the American Pharmacists Association
Volume53
Issue number6
DOIs
Publication statusPublished - 2013 Jan 1

Fingerprint

Health insurance
Drug therapy
Medication Adherence
Health Insurance
Osteoporosis
Drug Therapy
Insurance Coverage
Health
Odds Ratio
Electronic medical equipment
Electronic Health Records
Medicare
Systems Analysis
Health Services
Longitudinal Studies
Observation
Outcome Assessment (Health Care)
Research
hydroquinone

Keywords

  • Health insurance
  • Older patients
  • Osteoporosis
  • Pharmacotherapy
  • Women's health

ASJC Scopus subject areas

  • Pharmacology (nursing)
  • Pharmacy
  • Pharmacology

Cite this

Effects of health insurance on racial disparity in osteoporosis medication adherence. / Yoo, Ji Won; Kim, Sulgi; Kim, Sun Jung; Ryu, Woo Sang; Min, Too Jae; Shin, Hyun Phil; Kim, Kyudam; Choi, Jong Bum; Nakagawa, Shunichi.

In: Journal of the American Pharmacists Association, Vol. 53, No. 6, 01.01.2013, p. 626-631.

Research output: Contribution to journalArticle

Yoo, Ji Won ; Kim, Sulgi ; Kim, Sun Jung ; Ryu, Woo Sang ; Min, Too Jae ; Shin, Hyun Phil ; Kim, Kyudam ; Choi, Jong Bum ; Nakagawa, Shunichi. / Effects of health insurance on racial disparity in osteoporosis medication adherence. In: Journal of the American Pharmacists Association. 2013 ; Vol. 53, No. 6. pp. 626-631.
@article{349779f8080041afbe3d3024ae8c947d,
title = "Effects of health insurance on racial disparity in osteoporosis medication adherence",
abstract = "Objective: To explore whether racial disparity in osteoporosis drug therapy maintenance varies by health insurance coverage status. Design: Longitudinal observation study. Setting: Cleveland Clinic Health System (Cleveland, OH) from January 2006 to December 2009. Patients: 3,901 black and white female Medicare beneficiaries starting osteoporosis drug therapy. Intervention: Analysis of the health system's integrated electronic medical records. Main outcome measures: Drug therapy adherence (medication possession ratio ≥80{\%}) for more than 12 of 15 surveillance units and occurrence of extended nonadherence gaps for at least two surveillance units in a row. Results: Among patients with supplementary health insurance (n = 2,278), no difference was observed for drug therapy adherence (P = 0.17) and extended nonadherence gaps (P = 0.53) between black and white participants. When patients did not have supplementary health insurance (n = 1,623), blacks (36{\%} [95{\%} CI 28-47]) were less likely to adhere to drug therapy than whites (47{\%} [38-57]; odds ratio [OR] 0.34 [95{\%} CI 0.09-0.92], P = 0.004). Blacks (25{\%} [19-32]) also were more likely to have an extended nonadherence gap episode than whites (18{\%} [11-26]; OR 2.42 [1.13-3.50], P = 0.03). Conclusion: Similar to previous research on racial disparity in health services, racial disparity in osteoporosis drug therapy maintenance between black and white female older patients existed when supplementary health insurance was not affordable.",
keywords = "Health insurance, Older patients, Osteoporosis, Pharmacotherapy, Women's health",
author = "Yoo, {Ji Won} and Sulgi Kim and Kim, {Sun Jung} and Ryu, {Woo Sang} and Min, {Too Jae} and Shin, {Hyun Phil} and Kyudam Kim and Choi, {Jong Bum} and Shunichi Nakagawa",
year = "2013",
month = "1",
day = "1",
doi = "10.1331/JAPhA.2013.13061",
language = "English",
volume = "53",
pages = "626--631",
journal = "Journal of the American Pharmacists Association : JAPhA",
issn = "1544-3191",
publisher = "American Pharmacists Association",
number = "6",

}

TY - JOUR

T1 - Effects of health insurance on racial disparity in osteoporosis medication adherence

AU - Yoo, Ji Won

AU - Kim, Sulgi

AU - Kim, Sun Jung

AU - Ryu, Woo Sang

AU - Min, Too Jae

AU - Shin, Hyun Phil

AU - Kim, Kyudam

AU - Choi, Jong Bum

AU - Nakagawa, Shunichi

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Objective: To explore whether racial disparity in osteoporosis drug therapy maintenance varies by health insurance coverage status. Design: Longitudinal observation study. Setting: Cleveland Clinic Health System (Cleveland, OH) from January 2006 to December 2009. Patients: 3,901 black and white female Medicare beneficiaries starting osteoporosis drug therapy. Intervention: Analysis of the health system's integrated electronic medical records. Main outcome measures: Drug therapy adherence (medication possession ratio ≥80%) for more than 12 of 15 surveillance units and occurrence of extended nonadherence gaps for at least two surveillance units in a row. Results: Among patients with supplementary health insurance (n = 2,278), no difference was observed for drug therapy adherence (P = 0.17) and extended nonadherence gaps (P = 0.53) between black and white participants. When patients did not have supplementary health insurance (n = 1,623), blacks (36% [95% CI 28-47]) were less likely to adhere to drug therapy than whites (47% [38-57]; odds ratio [OR] 0.34 [95% CI 0.09-0.92], P = 0.004). Blacks (25% [19-32]) also were more likely to have an extended nonadherence gap episode than whites (18% [11-26]; OR 2.42 [1.13-3.50], P = 0.03). Conclusion: Similar to previous research on racial disparity in health services, racial disparity in osteoporosis drug therapy maintenance between black and white female older patients existed when supplementary health insurance was not affordable.

AB - Objective: To explore whether racial disparity in osteoporosis drug therapy maintenance varies by health insurance coverage status. Design: Longitudinal observation study. Setting: Cleveland Clinic Health System (Cleveland, OH) from January 2006 to December 2009. Patients: 3,901 black and white female Medicare beneficiaries starting osteoporosis drug therapy. Intervention: Analysis of the health system's integrated electronic medical records. Main outcome measures: Drug therapy adherence (medication possession ratio ≥80%) for more than 12 of 15 surveillance units and occurrence of extended nonadherence gaps for at least two surveillance units in a row. Results: Among patients with supplementary health insurance (n = 2,278), no difference was observed for drug therapy adherence (P = 0.17) and extended nonadherence gaps (P = 0.53) between black and white participants. When patients did not have supplementary health insurance (n = 1,623), blacks (36% [95% CI 28-47]) were less likely to adhere to drug therapy than whites (47% [38-57]; odds ratio [OR] 0.34 [95% CI 0.09-0.92], P = 0.004). Blacks (25% [19-32]) also were more likely to have an extended nonadherence gap episode than whites (18% [11-26]; OR 2.42 [1.13-3.50], P = 0.03). Conclusion: Similar to previous research on racial disparity in health services, racial disparity in osteoporosis drug therapy maintenance between black and white female older patients existed when supplementary health insurance was not affordable.

KW - Health insurance

KW - Older patients

KW - Osteoporosis

KW - Pharmacotherapy

KW - Women's health

UR - http://www.scopus.com/inward/record.url?scp=84890519808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890519808&partnerID=8YFLogxK

U2 - 10.1331/JAPhA.2013.13061

DO - 10.1331/JAPhA.2013.13061

M3 - Article

VL - 53

SP - 626

EP - 631

JO - Journal of the American Pharmacists Association : JAPhA

JF - Journal of the American Pharmacists Association : JAPhA

SN - 1544-3191

IS - 6

ER -